Aurisco Pharmaceutical is a Chinese CDMO specializing in oligonucleotide and peptide (TIDES) manufacturing, including the first generic oligonucleotide API inspected by the US FDA.
/PRNewswire/ -- Aurisco Pharmaceutical, a leading global Oligonucleotide and Peptide (TIDES) manufacturer, announced today that its site in Yangzhou, China has...